Comparison Study Between PET/CT and Whole-Body Diffusion Weighted MRI in the Detection of Distant Malignancies
NCT06205901 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2024-01-18
Summary
The purpose of the study is to compare the efficacy of 18F-FDG PET/CT and DWI WB-MRI in detection of distant metastasis of various cancers.
Conditions
- Distant Metastasis
Interventions
- DEVICE
-
PET-CT, MRI
whole body MRI and PET-CT for cancer patients with distant metastasis
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-01
- Primary Completion
- 2025-03-01
- Completion
- 2025-04-01
More Related Trials
-
Role of 18F-FDG PET/CT in Gastric Cancer
NCT05687552 ·Status: UNKNOWN
-
Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer
NCT05392205 ·Status: COMPLETED ·Phase: NA
-
A Study of Metabolic Agents Following Brain Radiation
NCT06150547 ·Status: COMPLETED
-
Comparison of Whole Body DWI to FDG PET
NCT06630845 ·Status: RECRUITING ·Phase: NA
-
Role of FDG PET/CT in Patients With Metastasis of Unknown Origin
NCT06055764 ·Status: NOT_YET_RECRUITING
-
18F-FAPI-RGD PET/CT in Various Tumor Types
NCT06094530 ·Status: RECRUITING
-
Comparing the Diagnostic Role of PET/MRI and of PET/CT Among Patients With Gastric Cancer
NCT03015298 ·Status: UNKNOWN
-
A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression
NCT01604512 ·Status: COMPLETED ·Phase: NA
-
A Study Evaluating the Value of 68Ga-Pentixafor PET Imaging in the Staging of Hematological Tumor, and Comparing It with 18F-FDG PET/CT Imaging
NCT06834412 ·Status: RECRUITING ·Phase: NA
-
PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer
NCT01892540 ·Status: COMPLETED ·Phase: NA
-
18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor
NCT06126705 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
18F-FAPI PET/CT in Patients With Various Types of Cancer
NCT05810324 ·Status: UNKNOWN ·Phase: NA
-
Comparison of 6-fluoro-[18F]-L-dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography (PET) and Multiparametric Resonance Magnetic Imagery (RMI) in Initial Exploration of Glial Tumors
NCT03525080 ·Status: COMPLETED ·Phase: NA
-
Multi-parametric MRI and Dual-energy CT in Patients of Gastric Cancer
NCT05508126 ·Status: RECRUITING
-
Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases
NCT00592462 ·Status: COMPLETED
-
Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic Cancers
NCT02966574 ·Status: UNKNOWN ·Phase: NA
-
The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis.
NCT06597526 ·Status: RECRUITING
-
Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma
NCT05681234 ·Status: COMPLETED ·Phase: NA
-
18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Diffuse Large B-cell Lymphoma
NCT02928861 ·Status: UNKNOWN ·Phase: NA
-
18F-FSPG PET/CT Imaging in Patients With Cancers
NCT03144622 ·Status: UNKNOWN
-
Comparison of FDG and FAPI in Patients With Various Types of Cancer
NCT04416165 ·Status: RECRUITING ·Phase: NA
-
A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.
NCT01083719 ·Status: UNKNOWN ·Phase: PHASE2
-
The Role of PET/MRI in Predicting the Outcome of Definitive Chemoradiotherapy for Esophageal Cancer Patients
NCT05855278 ·Status: COMPLETED ·Phase: NA
-
Energy CT in Imaging and Diagnosis of Gastric Cancer
NCT06869694 ·Status: RECRUITING
-
68Ga-labeled NY105 PET Imaging in Patients
NCT05691881 ·Status: UNKNOWN ·Phase: EARLY_PHASE1